CASE DISCUSSION
In Conversation with the Changemakers in AI and Heathcare
Presented India by Dr. Kelvin LiViews
0
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
The rapid clinical integration of artificial intelligence reveals a pronounced translational gap between algorithmic capability and operational healthcare delivery, particularly within image-intensive specialties such as ophthalmology. While machine learning architectures demonstrate exceptional...
Case Summary
- The clinical integration of artificial intelligence, particularly within image-intensive specialties such as ophthalmology, reveals a pronounced translational gap between algorithmic capability and operational healthcare delivery. Although machine learning models achieve high diagnostic performance in retrospective, in silico evaluations, their real-world clinical utility is frequently limited by complex human factors, economic viability, and workflow friction.
Speaker Profile
Dr. Kelvin Li
Head of Ophthalmic Innovation, National Healthcare Group Eye InstituteDr. Kelvin Li is a distinguished Consultant Ophthalmologist at Tan Tock Seng Hospital and currently serves as the Head of Ophthalmic Innovation at the National Healthcare Group Eye Institute. With extensive expertise in advanced ophthalmic care and clinical innovation, Dr. Li is actively involved in integrating cutting-edge technologies and modern treatment approaches into eye care practice.
He is widely recognized for his contributions to ophthalmology, particularly in driving innovation-focused initiatives aimed at improving patient outcomes and enhancing clinical efficiency. In addition to his clinical responsibilities, Dr. Li is deeply engaged in academic discussions, collaborative research, and medical education, contributing significantly to the advancement of ophthalmic sciences.
Through his leadership and commitment to excellence, Dr. Kelvin Li continues to play a pivotal role in shaping the future of ophthalmology and inspiring clinicians across the global healthcare community.
Disclosures
Assimilate by Medvarsity requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.